Ponesimod

CAS No. 854107-55-4

Ponesimod ( ACT-128800 )

Catalog No. M16202 CAS No. 854107-55-4

A potent, selective, orally active S1P1 receptor agonist with EC50 of 9.1 nM; shows weak activity on S1P3 (EC50=123 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 77 In Stock
10MG 120 In Stock
25MG 221 In Stock
50MG 383 In Stock
100MG 565 In Stock
500MG 1215 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ponesimod
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active S1P1 receptor agonist with EC50 of 9.1 nM; shows weak activity on S1P3 (EC50=123 nM).
  • Description
    A potent, selective, orally active S1P1 receptor agonist with EC50 of 9.1 nM; shows weak activity on S1P3 (EC50=123 nM); activates S1P1-mediated signal transduction with high potency (EC50 of 5.7 nM); causes maximal reduction of circulating lymphocytes at a dose of 3 mg/kg.Multiple Sclerosis Phase 3 Clinical
  • Synonyms
    ACT-128800
  • Pathway
    GPCR/G Protein
  • Target
    Lysophospholipid Receptor
  • Recptor
    S1P1
  • Research Area
    Inflammation/Immunology
  • Indication
    Multiple Sclerosis

Chemical Information

  • CAS Number
    854107-55-4
  • Formula Weight
    460.97
  • Molecular Formula
    C23H25ClN2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C1N(C2=CC=CC=C2C)/C(S/C1=C\C3=CC=C(OC[C@H](O)CO)C(Cl)=C3)=N/CCC
  • Chemical Name
    4-Thiazolidinone, 5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylene]-3-(2-methylphenyl)-2-(propylimino)-, (2Z,5Z)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bolli MH, et al. J Med Chem. 2010 May 27;53(10):4198-211.
2. Piali L, et al. J Pharmacol Exp Ther. 2011 May;337(2):547-56.
3. Sobel K, et al. J Biol Chem. 2013 May 24;288(21):14839-51.
molnova catalog
related products
  • ASP6432

    ASP6432 (ASP-6432) is a potent and selective antagonist of LPA1 receptor, does-dependently inhibits LPA-stimulated increase in intracellular calcium ion with IC50 of 11 nM.

  • Ozanimod

    Ozanimod (RPC-1063)is a potent, selective agonist of S1P1 and S1P5 receptor with EC50 of 0.41 nM and 11 nM respectively.

  • BMS-986020

    BMS-986020 (BMS986020, AM-152) is a potent, selective, orally available LPA1 receptor antagonist for treating idiopathic pulmonary fibrosis.